News

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference

ORLANDO, FL / ACCESSWIRE / January 24, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a pioneer in the science of using novel transdermal solutions and other innovative technologies, today announced details of the Company’s participation at the 2023 Transdermal and Microneedle Conference taking place January 23-24, 2023, at the Copthorne Tara Hotel, London, United Kingdom. Gareth Sheridan, Nutriband’s …

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference Read More »

Nutriband Inc. Commences Trading on Upstream Under NTRB

Nutriband among the first issuers to dual list on Upstream ORLANDO, FL ACCESSWIRE / January 5, 2023 /  Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), a pioneer in the science of using novel transdermal solutions and other innovative technologies, will become available today at 10:00am EST under the ticker symbol NTRB on Upstream, the revolutionary trading …

Nutriband Inc. Commences Trading on Upstream Under NTRB Read More »

Nutriband Inc. Will Be the First Company to Dual List on Upstream

Trading scheduled to Commence on Upstream January 5, 2023 ORLANDO, FL / ACCESSWIRE / December 30, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced today that it will be the first company to dual list on Upstream following recent approval. “We are proud to have a trailblazer like Nutriband as the first company to dual list on Upstream …

Nutriband Inc. Will Be the First Company to Dual List on Upstream Read More »

Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023

ORLANDO, FL / ACCESSWIRE / December 29, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced today that it has begun production of its AI Tape brand with an expected launch of the product line in Q1 2023. AI Tape is designed to share many of the benefits of traditional Kinesiology Tape. AI Tape further adds soothing and therapeutic …

Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023 Read More »

Nutriband Approved for Dual Listing on Upstream

Trading to Commence on Upstream January 5, 2023 under Upstream Ticker Symbol NTRB; all Upstream Participants Eligible to Receive Commemorative NFT ORLANDO, FL / ACCESSWIRE / December 14, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced its approval to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon …

Nutriband Approved for Dual Listing on Upstream Read More »

Nutriband Financials

Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3

ORLANDO, FL / ACCESSWIRE / Dec 5, 2022 — Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), a developer of transdermal pharmaceutical products, today announced financial and operational results for the third quarter ended October 31, 2022. Key Highlights: Generated record quarterly revenue of $620,000, up 118% over Q3 2021 Revenue for nine-months ended October 31, 2022, was $1,552,074, …

Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3 Read More »

Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022

Orlando FL, Dec 2, 2022 – Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announces that Gareth Sheridan, CEO, will be presenting at the RHK Capital Disruptive Growth Conference in New York City on Monday, December 5 at 10:20 AM.  Mr. Sheridan will present a corporate overview with a specific focus on the Company’s AVERSA technology and market …

Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022 Read More »

Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA™ Abuse Deterrent Transdermal Technology Patent

ORLANDO, FL / ACCESSWIRE / Dec 1, 2022 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) announced that the Canadian Intellectual Property Office (CIPO) has granted Canadian patent No. 2,937,649, entitled “Abuse and Misuse Deterrent Transdermal Systems,” with an issue date of November 1, 2022. This patent protects Nutriband’s AVERSA™ transdermal abuse deterrent technology being developed to prevent the …

Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA™ Abuse Deterrent Transdermal Technology Patent Read More »

Nutriband Supports Newly Published CDC Opioid Prescribing Guidelines

New guidelines reiterate need for abuse deterrent technologies and call for enabling clinicians to provide comprehensive pain management including appropriate use of opioid medications ORLANDO, FL / ACCESSWIRE / November 8, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) supports the new United States Centers for Disease Control and Prevention (CDC) clinical practice guideline entitled “CDC Clinical Practice …

Nutriband Supports Newly Published CDC Opioid Prescribing Guidelines Read More »

Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement

ORLANDO, FL / ACCESSWIRE / October 27, 2022 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), today announced that it has signed an exclusive manufacturing agreement with Fleur Marché for its CBD and Botanical Patch lines. Nutriband Inc.’s wholly owned contract manufacturing subsidiary, Active Intelligence will act as exclusive manufacturer for the lines of products. Founded in 2019 …

Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement Read More »